宏利:自願醫保佔醫療產品新業務70%
宏利調查發現,大部份受訪者早前獲政府派發一萬元現金後,77%用作加強個人及家庭的財務規劃,46%購買與健康相關產品。宏利香港首席產品總監兼康健主管紀榮道於電話會議上表示,公司銷售數據可見,今年自願醫保、危疾產品及年金受市場歡迎,今年醫療產品之新造保單中,60%為自願醫保產品,另外公司早前推出的新危疾產品反應亦良好。
他表示,未來宏利將繼續以康健業務作為主要發展策略,9月社交距措施放寬期間,對銷售表現有幫助,過往兩度推出感謝月優惠,市場反應亦良好。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.